ALLANTOIN News
ALLANTOIN currently has 0 news articles, with 14 predicted indications.
This page combines the AI-predicted indications for ALLANTOIN with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (14):
- parapsoriasis (99.0%)
- seborrheic dermatitis (99.0%)
- dermatitis (99.0%)
- pityriasis simplex (99.0%)
- seborrheic keratosis (99.0%)
- psoriasis (99.0%)
- severe nonproliferative diabetic retinopathy (99.6%)
- acrodermatitis chronica atrophicans (99.5%)
- neonatal dermatomyositis (99.5%)
- acne keloid (99.5%)
- secondary interstitial lung disease specific to childhood associated with a connective tissue disease (99.4%)
- amyopathic dermatomyositis (99.4%)
- hydroa vacciniforme, familial (99.2%)
- exanthem (disease) (99.1%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.